Close
Achema middle east
swop processing & packaging

Valicare GmbH extends GxP expertise

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio...

Symeres acquiries DGr Pharma to enhance regulatory expertise and broaden its biopharma capabilities

Symeres, a leading global Contract Research, Development and Manufacturing...

Syntegon delivers strong growth and EBITDA improvements in first half of 2025

Successful growth strategy delivers sales growth in H1...

Valicare GmbH, a wholly owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs. A new focus is on consulting services for the transition of products from the development phase to the GMP compliant manufacturing of investigational medicinal products. These services are complemented by the presentation and assessment of market-specific requirements, investigational drug management and the necessary regulatory interactions.

Addition to the team

To underline the extension of the service portfolio, Valicare has recruited Dr. Christin Erbach to join the expert team of engineers and scientists as a Senior GMP Consultant. Dr. Erbach has more than ten years of clinical service experience along with deep knowledge in quality management and legal pharmaceutical requirements. She also successfully supported pharmaceutical businesses during their establishment phase. “Her specialized knowledge in the area of clinical services combined with her legal background is an outstanding addition to Valicare’s consultancy business,” says Dr. Hans-Georg Eckert, site manager of Valicare in Frankfurt. “She will strengthen our competencies regarding the first GMP steps and the legal requirements for clinical products, addressing special needs for each development stage. This way, we are able to extend our approach of accompanying products along their complete life cycle.”

Valicare is significantly expanding its GxP and consultancy services for the pharma, biotech and ATMP industries to fulfill individual demands regarding products and projects from development to market release. As far as ATMPs are concerned, the company already supports customers in meeting regulatory requirements for more and more individual therapies and minimizing associated risks. Valicare also offers complete solutions for the production of ATMPs as well as consulting and supporting services, right through to the production of the first investigational medicinal products.

Latest stories

Related stories

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio...

Symeres acquiries DGr Pharma to enhance regulatory expertise and broaden its biopharma capabilities

Symeres, a leading global Contract Research, Development and Manufacturing...

Syntegon delivers strong growth and EBITDA improvements in first half of 2025

Successful growth strategy delivers sales growth in H1...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »